PCNA and cancer: Efficient CRISPR editing and cell suppression were observed in these nine Cas9-expressing cell models, evidenced by robust depletion of the RFP-positive cells with sgRNA targeting the general cancer essential gene proliferating cell nuclear antigen (PCNA) (fig.